2015 | 2014 | ||
(in millions) | |||
Routine clinical testing services | $ 4,580 | $ 4,549 | |
Gene-based and esoteric testing services | 1,754 | 1,676 | |
Anatomic pathology testing services | 631 | 648 | |
All other | 528 | 562 | |
Total net revenues | $ 7,493 | $ 7,435 |
• | The Company is responsible for the adequacy and accuracy of the disclosure in its filings; |
• | Staff comments, or changes to the Company’s disclosure in response to Staff comments, do not foreclose the Commission from taking any action with respect to the Company’s filings; and |
• | The Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
XR.:5=%*T'2@?HJ@C?B&&B&.)YI38YP#%G&D M>74FRI( "12@((.#ID@ GV V4*B: MAVZVT12B@3\ /?DQ(4 ,H!:QJ\ M;UF,WC@M@O)]&4"Y\B& K&+H'5# E@K6]VR0!5!L<6'YQORR;@* LF"(6^)8 M;;G&*L 8H_X^.FU^)B980 (S!V; D4PS' H"PPG@KX@WPVMU !(8\+.G7^HX M)'T<(QCJT"R^J-@!*0=0@' ,W"BDGU8S*.T$7"3]%XVA*#AH !%"ZV#8CGZ* M&\ $Z!Z60([MK@W 9P2E)[\V/6%@F%AAP, T04DK>72;G$2 EB SPWK7P,PQP3Z)YCL=2F _[UIF^FN-I^5%>-Z M'0$:RB1(GVKI+TB4(A:."@!#H1"#%%6SSZ0*H$"#\$ >(\H/QR;@OH+(3%\< M?"*B(E*@]2#@BLU351';5+X#1&!BFM.B0]#VI5(1$8JU(<:G0B@D!X9H?!L1 M@ *TY,"_U4YY5_/; ]L5*_EL$"A2VU,-AT2 /]KI .F1 ? 2 MU!YB $A"4@(0Z10=!9>@!K2LAYFL42%LD6N4PAA_L3J2+IQRUF!XGONH_ ME&A(C#"J66(*W[^$E2M>89J P5@W MJ#=6TYE^*@9#EOD[H@$,??4!A=VDIJ<4";*@:HNG"1/YMY4-#G>O24#8Q$6N M_$P@GA7Q%>K = > 8",='H.E/--Q;)@](2-(Y7%0A?QP5COB1T,/<@!P MK4B "S' V.25384P )??8FFYX@>W^I "IP3Y:H[*Z*Z>E@J. V%=H*@70?N( MU#7$>) -Y?73 4@ K0M,0 ,9U$:ZWO&!?EH9@WP)L+F**0!WY4FS2N2C&?Q( M:QZI*L[_OC==2(VI=@QJ[D0$T( F?H2B[9SJ M1VP6P1!"LR"LT]X6+KK'^F#R(&I<$%$'0 J8TK:J13T14@N"_\CI.;A-"HA M!%Z6RG?19\BV$4#>W 7@!IMW(((%G#'?M;>Q>JUOT$)0=H%ZXM,%\<<1,=.9 M&S)B)6Z,A![1:JSZ%( (?#9L],&J0JS9S 5UU8FV!>I9&[(T0,52QP,1P&2A M9>B,D)&GBH;-IS^:'RD!EH.(3!^$'SC(L46I2+^DSP$WFT.^A@X_4X;(Y[X+ MDDC;SL8:88"2R0:*S^I1M)0N[:Q.6Q .\U' #DD K045BCF)&52=W?,_4EFJ M!X7:-0FE:5&%!&V+*.!3M() :(% M?;LUGU9EWR907(NPJVI]C"2L_R5?4.DU>2OVZ5;W1C8\4Q(_@.8W)_'#1/() M\5\&%PCKMF2.&8!YM&J.SY'3JN+[R!@B"D#>(@VB5!49&13UFX@)8WMTV5P[ M7I/BQPPL;G(>JSQ%+*V:J+S<;56"L,P?;0"\/=9I*C: 'Q_/" ) E1]\6X3# M Z=/W0D"Y7^9PP'PQ2&.'CT0+H1IFO42C^2),?G*4UZ-)QS R VDUMP8(E8]]QT1M?I9D8$WOYRKRW][-YJ3 $H+?0G[$5H8_)^ Z%5QS0AD$9PN*5'+,=6 MY3)0O"80/- LHQ-WZF-6Z*00:!.!H6*!IB$ )-968%)N$Z%"':<\1$(D'Q9+ M*P1GY+5+_H12,Q -7#NA$LK,E_/,1!.1,!!!B0!8Z\3%]604M MY;)T D%2)?4GX1 5,B<0/(_B%7 ,DTD)J7D(O!I,]/_4@6N@:_SB61*62 MA@]A/*BS@]HC*FVW/Y8V4*,3?D 8/S0E.K8W-@:X$&(6)'JH$7OW+&T(5QE1 M6^*6'Q(75VU5'XAW<\V$30;Q.8@5+?#2,22R5QTF.PP2B?^0)#67+G?S:5 MAE5W'S!8&H[2?'=DB1"19"<",DMF=3AR1YSE@RS5?(@%:R%R>\\B2/Q0AP=H M'X/G$5'7?.+R? F1'MQQ(0; P:@ IP(3PF(D1""A/UAP$@C0C197A$* ;! M8\.2'Z%0811F8?=HCQ9V8?N8CULP?K3% ?@(>?33O(Q@EU65KF8'1_",2SB M7(^X4W,FB/;6.. G*E#5@YW$5X$C-K@G/O\W>(*->(E]-B8 YHH%P0!!DX(; M>5^;>'"A2!]>R! <%X"MPW@"44S[U( (Q2@1( _^MG8R.2>E-R@+*1JDQ4X/ MI(T-05)LIXRTYD#>MU4"!5H1]"#F4$^T!U%%]I(,(6S38H,><4$]*#>#@Y($ MD3$IPX,Z4T,CJ5FJ%98*E&JH HB#KS 3(IYE.JIEB#AHQH>1#51Q^;:1$R)2)APWIM M@@"S!%6Q C)B61#%5(0!X)7/A81@XW!I29?RXHL(=7PX4BH2%V1K19B@467! MU0"?>1 F!"Z4R6I.AX52?Y-BLC<]E!E;K%9:*K*:#3%T]<$%)*&;CED?!;!^ MU,=@^[15!# !=9!5X:>:?J=ISK0E=BD0Y4>5I.E53N:(F70CU#4 $G> % M_^ F#Y28'\#Y#Q>T4W[B2\\"A:(#+S9TH/=E9V*E;LO%H"R'($\7$7MW'\4V M$LM45L$D'T 27Q7SBMNA'B=S39D98?,I$)_C([]#, 9 /#2R M!6$R/6QD+0&'1'N57I1,00 0J5-6UB=@&$*:6I9(0%2ITY4+ 1<:$5 F;SH3)+M2EN")5P[%R1/ B4I-BUN9E5&QJ+_,'P@I#[!(P$2,$HLEZKU09L&05)^R%<$ MDU_>: )$ &^\SVM9! ,@$1^@S4NTAT,T(V"6C72@E5%&H(XLA_$"A_UT:J: M4:!6Q90+4:"KRC>\JDK_A4>Z9Y7AHETF@D%U1*() C+LN! K-90GH9+)8U^/ MA3SODEWT%$L\4J-I^3^Q5T[H &F>:2BVS1U=QZ8=+]CVO.J0$ M4641%JMM8@#%T* YZX,IDG+_<@0$(U^+2LH,"KHR-(404*=4"T 1"C3G0 M!!!^5$.,S@0V6X:MI@FT0JEX:2L?VEBI?J*17N,U,(L98%DZD$41"D!B R4X M59H?/(A!BJ5=?=6 M5[8Y)^)=>. M3XA\?$( D]H9/$ R6FT7^A!/XN1LQ> I,I3$8B"MI>#%8=#U1)".HL@R)N3 M*Z9Y+1&HOO,UTPD^G80K;))F;>E>K,< 6^"O.^>Y,$):LS@M8EN[MQN!CY>V M8%,O_^)D( @8."O$M_/!/DG3+PXYGCR7MY>A ,K%9 =%#$/3@^&'1Z>KN$I* M-"3Z>$V7NP0%0A0H.(RT0+OX:M[[$L1@( 4 )08D)/!1#%N07P9S7/NXCTNB M)&MK$(&:PD)2.^7YPFRBDO=(8>T1?#G:'@C(7?SD2:(W8P*Y8$?LL_!!"B^L M*M7TDT=LO 00/!)3!TJ+&'D%505'$87G@CN[H+DJAF,3G5YSIS^'N7CH93K2 M;;Z:57$Z -56$P( CN#!!6ER(5V\K P CMXQ>B)1.6G2QW/J@.C! X* EY5UH9)>#&= M@5X=I\#P^5I%DW9-^I3RU7+9!< ]XF<%9,OQ!JL4D5 EHD.:WYGV$XB,FOU&@"6[%7717OW',Z184+F4,SG=2.6%L>P]FI% MXF[WM<.$:Y5 @K\L*:R#)*JU MIJOJ4['%:*\0RS?3,I+49Y!RB=&;$6[U< OE\;4FU%]^VP0P!5$'VA,HQS*$XJ@Y@(*6O9% $]%,,#@1S= A&_ C MGTMZ[-'99X$V@LV:[#'')8$PQ,D GR,Y://5:*'1',T0/*"@ <.8;L:I":=> M)LU99[DH6C,*VGW2 -Q-$,.WVUGR6FWZ&.O4<\3$JO^P8,0Y ?*@WF=!4DM= MNYC,N2A&F15Z7SK"2^K%#Q-]$JG'F"O2WB'! _C!W"JY2,>]&(?SW3DA4[J" M1?P@#WWYW_])H57 "8%\5:J/:<;="=)T1I7PA!+E%SAP5V,IP0,?LML3ZR40 M_AC>K=HMP2RZ(M?9JAZN;192TP!B'*RP130S)-]%-2I56UHO91(*T*0*38TV M/A!_.P#,_84 >T):U50@P)T]HN MHL GS!X3UCP*))#L<46:8S$MR 72FNFK0B-_6N@1 .B"ON*,,NEGDMB9]H4! MDNIM?N-(KH2GB#+OO(CS+:HEYC?="5F=S7DGF[+TX>(@\=ZO21$WFH;'5[DI M^9/YFR 3\.$)H9);P@^/%XWHXMT' 98^8P#:*A^#:N?+F@#9+A__T7XNYY4 M8*4@4])$.JD@A(/6D32I-0*%&BP!G2X0YDU*+<+M=_'"%,&RWY*P'8R1H9R, M?;3'AE'XM.#[<+D':'1<9YI\>&?0A>VJ]*"%9( /# >Z3&07K+NB1H MI( F"":0!2!)@3HXU5X/ 5#O]XY@B!Z+60Y=:L,%G9,E><+8GV4N!U8Y$7#. M%'^%=),F?)P F#ZRQ!=PB#0!,/R%_)4WG35^WE,,IU0^='2D?"&0P8R?;&8Z MT))Y*^V1]QJ9-34N!4X1NAYWG/3D(P'L#&\0-]I$Q;[I\]ZB2!2%U=Z0==/L M>]3/RP*BKD6P&7 M ,>CX)EV/(W(*!<=&$'FL,+HFE8SP2OTJD454/:1Y1/!..]BC#OR^1>1YD]- M$=FC?&ASQW8"1"& B - A79) ^4V0:#? 6YM; IC%&-(ES@A" M:0Z,&6#+8IQQ)U F";(!YG^1N705T#"4 ;YG39]&G5JU0&*&&XP=BA3I *T M938P1Q9J2*6[ 30DS#/RVH*--WI- &J+A%#% M0DDHL 74@00-'T.&KI.+1HD\9)Y_"2J !(YZMY3VR "A0H(1&C8HX %\"MH MO>MJ BD NC*:@"N?#$!HO@A(:ZY""R]<30!0S E *K&.,DHYLJJBBBC_V;+" M*KD&)$B 0-4$,( 4$D]J@#H,26IK !MW:BP SOZ):Z[ MN!'I@DDD*< >228 M($*B=NQ,)B@19"\BP?"R"90!Z!M( )FBPRF4P_)2 &G-"I@0@)!NLPFS1P4 M2(( Y''Q)@$B"&5$"1!(X,<;_P0T4!@E"*ZV &;SD"SDDGKJ4."D"H 44 8, ME#7#EH(4S$H)>BZ *>TL9DN^(AC@P))D"N4 !@1(B54&>#!NIH(ZU;0FRR0B M1B8%;LJ(2Y6^W$F>.3N"\8 MG&P @5WA"@E.CQ*D2]@"4A. 6,)O8W%.C?E MMMN=!#A 3!&?"FXJVGJK;3F9#%VJ@0D0H-!;_W ;&BJ";6],:[">XN+GTR#I M,J"AAVHBIB$H]:(3)P'$!,S*NVYJK)CZBD1 )[TJ?JE:8XM,*"(V_?18*+J" MDI@X5@U (,("0/:V99=M$B"! AIX+=';F)(J-Z2N0Z(]^5_&)!S8*&? MTU&ZANZ3R#JZ##,51X3@$R@N?2$VLCU=L192);"ZOLD I&KM"X&A-#V@5&<[ M,@FE@M+FA^H,8T5,:+OO]NJ E.D]T]RJ^"YF"Z#OY19 :DJ@FFHQ8^NJ7&@HN3N2+^&!$B2;V (&*%GQH.1YNR4WF\VKH;HK MC(LYO&_'/2\#]$9 2?\)?D>R 3&Z_/PW+TE!JE//;IS* G6'HC4J(&:;UL! MA)4U(NH/6_6G!(JV#E>A6*ZN>LA=^UQ[J]-_J=>"-"-_=)GX,BD >VTBQGCY M?3R^?___!Z!' G:UC!$C @AI "A<]#B"6.T +B)&4"I'K%AMB3P&4,#N4J81 M+H"+ \?X7-8 )95D\;XBB"M<5[F"D*, R#_ M9 (L;&"1)C INL2,8844U@2"%L7W#05Z\Q)._O(B,YDH<"#Z"0F\"JD ]#G1 MDY_T"3$8Q#Y/YHAFIT0E;HBRH@C$;R ,A)Q_9+(G4( " 5L0TYP,0(RED%(E M#$C 2(0 ?*,T2 F#(Q,2!B? !P1 KR)4L)@WL_R)G) 'M$%QB6B%3$SO_6 !:2$ V%%%NU[*9B M)L\5==.6,6V 5*8:6M:VUK5]80 H(J04Y'P(*U51BV1?VQQPQ12!G)W ST"[ M6^(6]Y\:DY-F#36;$2V%0U")K''Q=M:O2M>ZUPVH M0854PI938-^4V':$L* M-V+7O.=%;WJ)!4Q0D (XYOK0 [8 8WN%M\S*O"_*NW-6HV.%BQ67/G*J&R.MC#'P8Q:F"T-_ , MCYC!1/$!A!E/)G&,C5@)D5@,_!1U*6HI$E!3B'6\8QZ;]8K)?7&0HPKCL SE M-2?A#:3ZYK-6A^JVQT^&\H=C%E/:AHA YNKU*R[30E%FE3EY#+7V ]]K7OP9VL(4];&(7V]C' M1G:RE;UL9C?;V<^&=K2E/6UJ5]O:U\9VMK6];6YWV]O?!G>XQ3UN^&=[SE/6]ZU]O>]\9WOO6];W[WV]__!GC !3YP@A=